Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    FUJIFILM Irvine Scientific
    2 June 2025

    Fujifilm rebrands life sciences companies to strengthen position as strategic Partners for Life, offering end-to-end solutions

    FUJIFILM Irvine Scientific becomes FUJIFILM Biosciences, providing a full spectrum of life sciences solutions built from a 55-year history as a cell culture pioneer FUJIFILM Diosynth Biotechnologies will be known as FUJIFILM Biotechnologies, serving global partners seeking CDMO services...

    5G
    9 June 2025

    More on the Wilson Pro Enterprise 4330

    Stronger signals, better communication—everywhere indoorsExperience seamless communication and improved coverage within large buildings with our In-building wireless solutions. Our advanced In-building cellular 5G repeater systems amplify weak signals, ensuring reliable connectivit...

    A busy station full of people. A great place to sit and experience all types of human behaviour.
    28 May 2025

    Want to know the secret to better business and a more fulfilled team?

    In a world obsessed with strategy and tech, the real competitive edge lies in understanding people. Human behaviour training isn’t just “soft skills”—it’s the hard truth behind better leadership, faster conflict resolution, stronger communication, and thriving teams. By recognising yo...

    www.nuclera.com
    28 May 2025

    Nuclera and Cytiva collaborate to accelerate characterization of proteins for drug development

    Collaboration combines Nuclera’s eProtein Discovery System, which accelerates protein expression, purification and optimization, with Cytiva’s Biacore SPR system, which characterizes molecular interactionsCollaboration allows researchers to progress rapidly from DNA to purified and...

    Laboratory Space at The EpiCentre
    28 May 2025

    Cambridge’s success in fund-raising for start-ups and scale-ups benefits the whole region

    A new analysis by Dealroom for Founders at the University of Cambridge showed that Cambridge startups and scaleups raised an impressive $2.3 billion in 2024, the second-best year on record and almost double 2023’s $1.2 billion that is great news for the Cambridge region as a whole. ...

    Sapio logo
    28 May 2025

    Sapio Sciences appoints Gordon McCall as Chief Operating Officer to drive global operational excellence

    New role underscores Sapio’s commitment to operational excellence and elevating customer delivery across global markets ...

    hero
    1 May 2025

    SIRS 2025: Insights on Schizophrenia Research, From Rights Based Care to Digital Biomarkers

    This year’s Schizophrenia International Research Society (SIRS) 2025 Congress in Chicago brought together leading scientists and researchers, exploring the latest advancements and ongoing challenges in understanding and addressing schizophrenia. Michael Spilka, PhD. shares his key insig...

    Hero
    3 April 2025

    Cambridge Cognition selected for two Phase 3 Trials combining digital cognitive and voice solutions

    Cambridge Cognition (AIM: COG), the brain health software group specialising in digital products to advance clinical research and patient treatment, has been selected by a major pharmaceutical company to provide digital cognitive and voice assessments for two Phase 3 clinical trials in ...

    Banner
    10 April 2025

    Cambridge Cognition Secures £1million Contract for Phase 3 Autoimmune Disease Trial

    Cambridge Cognition (AIM: COG), the brain health software group specialising in digital products to advance clinical research and patient treatment, has been selected by a major pharmaceutical company to provide digital cognitive assessments for a large Phase 3 autoimmune disease clinic...

    Design team
    23 May 2025

    Cleanroom Solutions embracing the future to elevate their large-scale facility construction provision

    The Guardtech Group’s heritage turnkey brand are utilising state-of-the-art software to take their offering to another level ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 93
    • Page 94
    • Current page 95
    • Page 96
    • Page 97
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS